The use of a CD163-specific nanobody-based immunotracer as a clinical imaging agent to study immunosuppressive tumor-associated macrophages

Activiteit: Talk or presentation at a conference

Periode16 okt 2023
Evenementstitel5th Research Day in Tumor Immunology and Immunotherapy
EvenementstypeConference
LocatieLeuven, Belgium
Mate van erkenningNational